Age and ethnicity in cirrhosis

Journal of Investigative Medicine

Volumn 62, Issue 7, 2014, Pages 920-926

  Sajja, Krishna C ^a   Mohan, Desh P ^a   Rockey, Don C ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

African American; Alcohol; Hepatitis; Hispanic; Nonalcoholic steatohepatitis; Race

Indexed keywords

ALCOHOL;

ADULT; AFRICAN AMERICAN; AGE; AGED; ALASKA NATIVE; AMERICAN INDIAN; ARTICLE; ASIAN; AUTOIMMUNE HEPATITIS; CAUCASIAN; CLINICAL FEATURE; COHORT ANALYSIS; DEMOGRAPHY; ETHNICITY; FEMALE; HEPATITIS C VIRUS; HISPANIC; HOSPITAL ADMISSION; HUMAN; INDIAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PACIFIC ISLANDER; RETROSPECTIVE STUDY; TREATMENT OUTCOME; AGE DISTRIBUTION; ETHNIC GROUP; ETHNOLOGY; MIDDLE AGED; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADULT; AFRICAN AMERICANS; AGE DISTRIBUTION; AGE FACTORS; AGED; AGED, 80 AND OVER; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; UNITED STATES; YOUNG ADULT;

EID: 84941353638     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.1097/JIM.0000000000000106     Document Type: Article

References (43)

1. Friedman SL, Rockey DC, Bissell DM. Hepatic fibrosis 2006: report of the Third AASLD Single Topic Conference. Hepatology. 2007;45: 242-249.
2. Rahimi RS, Rockey DC. Complications of cirrhosis. Curr Opin Gastroenterol. 2012;28:223-229.
3. Starr SP, Raines D. Cirrhosis: diagnosis, management, prevention. Am Fam Physician. 2011;84:1353-1359.
4. Mallat A, Hezode C, Lotersztajn S. Environmental factors as disease accelerators during chronic hepatitis C. J Hepatol. 2008;48:657-665.
5. Thein HH, Yi Q, Dore GJ, et al. Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression. Hepatology. 2008;48:418-431.
6. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 1997;349: 825-832.
7. Wright M, Goldin R, Fabre A, et al. Measurement and determinants of the natural history of liver fibrosis in hepatitis C virus infection: a cross sectional and longitudinal study. Gut. 2003;52:574-579.
8. Stinson FS, Grant BF, Dufour MC. The critical dimension of ethnicity in liver cirrhosis mortality statistics. Alcohol Clin Exp Res. 2001;25: 1181-1187.
9. Kramer JR, Davila JA, Miller ED, et al. The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases. Aliment Pharmacol Ther. 2008;27:274-282.
10. Rahimi RS, Rockey DC. Complications and outcomes in chronic liver disease. Curr Opin Gastroenterol. 2011;27:204-209.
11. Colli A, Fraquelli M, Andreoletti M, et al. Severe liver fibrosis or cirrhosis: accuracy of US for detectionVanalysis of 300 cases. Radiology. 2003;227:89-94.
12. Caldwell SH, Lee VD, Kleiner DE, et al. NASH and cryptogenic cirrhosis: a histological analysis. Ann Hepatol. 2009;8:436-352.
13. Caldwell S Cryptogenic cirrhosis: what are we missing? Curr Gastroenterol Rep. 2010;12:40-48.
14. Verma S, Torbenson M, Thuluvath PJ. The impact of ethnicity on the natural history of autoimmune hepatitis. Hepatology. 2007;46: 1828-1835.
15. Bambha K, Belt P, Abraham M, et al. Ethnicity and nonalcoholic fatty liver disease. Hepatology. 2012;55:769-780.
16. Centers for Disease Control and Prevention. Youth risk behavior surveillance: national college health risk behavior surveryVUnited States, 1995. MMWR CDC Surveill Summ. 1997;46:1-56.
17. Browning JD, Szcepaniak LS, Dobbins R, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387-1395.
18. Puppala J, Siddapuram SP, Akka J, et al. Genetics of nonalcoholic fatty liver disease: an overview. J Genet Genomics. 2013;40:15-22.
19. Krueger PM, Coleman-Minahan K, Rooks RN. Race/ethnicity, nativity, and trends in body mass index among U.S. adults. Obesity (Silver Spring). 2014;22:1739-1746.
20. Pearlman BL. Hepatitis C virus infection in African Americans. Clin Infect Dis. 2006;42:82-91.
21. Pyrsopoulos N, Jeffers L. Chronic hepatitis C in African Americans. Clin Liver Dis. 2005;9:427-438.
22. Verma S, Bonacini M, Govinarajan S, et al. More advanced hepatic fibrosis in Hispanics with chronic hepatitis C infection: role of patient demographics, hepatic necroinflammation, and steatosis. Am J Gastroenterol. 2006;101:1817-1823.
23. Kirk GD, Mehta SH, Astemborski J, et al. HIV, age, and the severity of hepatitis C virus-related liver disease: a cohort study. Ann Intern Med. 2013;158:658-666.
24. Bataller R, North KE, Brenner DA. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatology. 2003;37:493-503.
25. Guo J, Loke J, Zheng F, et al. Functional linkage of cirrhosis-predictive single nucleotide polymorphisms of Toll-like receptor 4 to hepatic stellate cell responses. Hepatology. 2009;49:960-968.
26. Huang H, Shiffman ML, Friedman S, et al. A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C. Hepatology. 2007;46:297-306.
27. Grunhage F, Hochrath K, Krawczyk M, et al. Common genetic variation in vitamin D metabolism is associated with liver stiffness. Hepatology. 2012;56:1883-1891.
28. Marcolongo M, Young B, Dal Pero F, et al. A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C. Hepatology. 2009;50:1038-1044.
29. Pradat P, Trepo E, Potthoff A, et al. The cirrhosis risk score predicts liver fibrosis progression in patients with initially mild chronic hepatitis C. Hepatology. 2009;51:356-357.
30. Huang H, Shiffman ML, Cheung RC, et al. Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C. Gastroenterology. 2006;130:1679-1687.
31. Lempicki RA, Schlaak JF, Murphy A, et al. Genome-wide single nucleotide polymorphism analysis identifies unique integrin beta 5 (ITGB5) haplotype in advanced liver fibrosis patients. Hepatology 2009;50:942A.
32. Hillebrandt S, Wasmuth HE, Weiskirchen R, et al. Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans. Nat Genet. 2005;37:835-843.
33. Skill N, Wu J, Xu Y, et al. Lysophosphatidic acid aberrancies and hepatocellular carcinoma: studies in the MDR2 gene knockout mouse. Cancer Invest. 2013;31:145-155.
34. Campbell JS, Hughes SD, Gilbertson DG, et al. Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma. Proc Natl Acad Sci U S A. 2005;102:3389-3394.
35. Czochra P, Klopcic B, Meyer E, et al. Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice. J Hepatol. 2006;45: 419-428.
36. Thieringer F, Maass T, Czochra P, et al. Spontaneous hepatic fibrosis in transgenic mice overexpressing PDGF-A. Gene. 2008;423:23-28.
37. Jia D, Duan F, Peng P, et al. Up-regulation of RACK1 by TGF-A1 promotes hepatic fibrosis in mice. PLoS One. 2013;8(3):e60115.
38. Wandzioch E, Kolterud A, Jacobsson M, et al. Lhx2-/-mice develop liver fibrosis. Proc Natl Acad Sci U S A. 2004;101:16549-16554.
39. Warskulat U, Borsch E, Reinehr R, et al. Chronic liver disease is triggered by taurine transporter knockout in the mouse. FASEB J. 2006;20:574-576.
40. Takehara T, Tatsumi T, Suzuki T, et al. Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses. Gastroenterology. 2004;127:1189-1197.
41. Hillebrandt S, Goos C, Matern S, et al. Genome-wide analysis of hepatic fibrosis in inbred mice identifies the susceptibility locus Hfib1 on chromosome 15. Gastroenterology. 2002;123:2041-2051.
42. Bell BP, Manos MM, Zaman A, et al. The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance. Am J Gastroenterol. 2008;103:2727-2736.
43. Sofair AN, Barry V, Manos MM, et al. The epidemiology and clinical characteristics of patients with newly diagnosed alcohol-related liver disease: results from population-based surveillance. J Clin Gastroenterol. 2010;44:301-307.